FAS: "Deltiba" in Russia will cost 19 times less than in the reference countries

73
1
AK&M 26 January 2022 17:00

The anti-tuberculosis drug "Deltiba" in Russia will cost 19 times less than in the reference countries. The decrease was made possible due to the expansion of the list of vital and essential medicines (VED). The drug belongs to the INN "Delamanid", which has been included in this list since 2022. The FAS has agreed on the price of the drug declared by the manufacturer R-Pharm, the service said in a statement.

INN is an international nonproprietary name of a medicinal product recommended by the World Health Organization (WHO). Defines pharmaceutical substances and active pharmaceutical ingredients of a medicinal product.